Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. April 2018 16:16 ET | Quelle: Qu Biologics

Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease

VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a Vancouver, Canada-based biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique...
08. Juli 2014 08:30 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania

PHILADELPHIA, July 8, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced execution of an agreement to seek South African government approval...
13. Dezember 2012 10:00 ET | Quelle: DeSantis Breindel

Inspiring New Documentary Short "Fire With Fire" Helps Spread Awareness About Groundbreaking Advance in Cancer Treatment

New York, NY, Dec. 13, 2012 (GLOBE NEWSWIRE) -- Who would dare to pit one fatal disease against another… inside the body of a seven-year-old patient? Immunologist Dr. Carl June is achieving...